Commissural alignment and the ACURATE neo2 transcatheter aortic valve: Impact on valve performance

Background Transcatheter aortic valve replacement (TAVR) is increasingly being used to treat severe aortic stenosis in younger patients. Accordingly, lifetime management regarding future reintervention and coronary access is a concern. Aims To assess the impact of commissural alignment on ACURATE ne...

Full description

Saved in:
Bibliographic Details
Published inCatheterization and cardiovascular interventions Vol. 104; no. 1; pp. 115 - 124
Main Authors Travieso, Alejandro, Toggweiler, Stefan, Montarello, Nicholas, Renker, Matthias, Tirado‐Conte, Gabriela, Loretz, Lucca, Charitos, Efstratios I., Kim, Won‐Keun, De Backer, Ole
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.07.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Transcatheter aortic valve replacement (TAVR) is increasingly being used to treat severe aortic stenosis in younger patients. Accordingly, lifetime management regarding future reintervention and coronary access is a concern. Aims To assess the impact of commissural alignment on ACURATE neo2 transcatheter aortic valve (TAV) performance. Methods COMALIGN‐neo2 was an observational, retrospective study enrolling consecutive TAVR patients treated with the ACURATE neo2 (October 2021 to October 2022). The degree of commissural (mis)‐alignment (CMA) with the native aortic valve commissures was determined and transvalvular gradient, effective orifice area, patient‐prosthesis mismatch (PPM), and aortic regurgitation (AR) were assessed. Results Among 825 patients, the mean age was 80.7 years and 42% were female. Commissural alignment was achieved in 60% of cases; mild (26%), moderate (9%), and severe misalignment (5%) were found less often. Severe PPM occurred more frequently in patients with severe CMA (14.7%) compared to aligned valves (p = 0.034). By multivariate analysis, severe CMA (odds ratio [OR]: 3.12, 95% confidence interval [CI] [1.09–8.90]; p = 0.033) and lack of postdilatation (OR: 3.85, [1.33–11.1]; p = 0.012) were associated with severe PPM. Higher rates of ≥mild AR (51.4%) were found in TAVs implanted with severe CMA compared to aligned (34.3%), mildly (38.1%) or moderately (36.0%) misaligned TAVs (p = 0.030). Multivariate analysis identified severe CMA (OR: 2.05, [1.05–4.02]; p = 0.037) to be an independent predictor of ≥mild AR. Conclusions COMALIGN‐neo2 is the largest study to date assessing the impact of commissural alignment on acute TAV performance. Severe CMA with the ACURATE neo2 platform was associated with worse valve hemodynamics and increased risk for mild AR.
Bibliography:Commentary: Commissural alignment beyond coronary access: Accurate neo experience
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:1522-1946
1522-726X
1522-726X
DOI:10.1002/ccd.31089